Efficacy and Tolerability of Beta Hydroxybutyrate Ester in Patients With Amyotrophic Lateral Sclerosis (ALS)

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2025

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DIETARY_SUPPLEMENT

Beta Hydroxybutyrate Ester (KetoneAid KE4)

see arm/group description

DIETARY_SUPPLEMENT

Placebo

see arm/group description

Trial Locations (1)

RECRUITING

University of Ulm, Ulm

All Listed Sponsors

lead

University of Ulm

OTHER